Gravity Medical Technology is dedicated to enhancing access to advanced stroke treatment through innovative medical devices. Their flagship products include the Supernova Stent Retriever and the Neutron Reperfusion Catheter. The Supernova Stent Retriever is a stent-based device designed for the retrieval of thrombus, featuring a collapsible, self-expanding stent that utilizes patented Spiral Fusiform Cell Technology for improved efficacy. This device is engineered for optimal delivery and retrieval, ensuring that it can effectively restore blood flow in patients experiencing severe strokes. The Neutron Reperfusion Catheter complements this technology by providing enhanced kink resistance and trackability, along with a robust hydrophilic coating that improves its usability during procedures. Together, these devices represent a significant advancement in the field of neurointervention, aiming to democratize access to life-saving stroke treatments globally.

The company emphasizes a collaborative approach, leveraging the expertise of leading professionals in neurology and biomedical engineering to develop solutions that address the disparities in stroke care access. Gravity Medical Technology's mission is not only to innovate but also to ensure that these advanced treatments are available to underserved populations worldwide. Their commitment to research and development is evident in their ongoing clinical trials and partnerships with healthcare institutions, which aim to refine and expand the application of their technologies. By focusing on both technological advancement and equitable access, Gravity Medical Technology is poised to make a substantial impact on global stroke care.

United States

Leveraging our deep experience in stroke medicine and bio-engineering, we have developed the world's most powerful and cost-effective solutions to save millions of lives impacted by ischemic stroke

Gravity Medical Technology

Company Details